RetroSense Therapeutics launches clinical trials on 1st human patients

Ann Arbor-based RetroSense Therapeutics has begun patient trials on its gene therapy technology (it helps restore vision), Which is the first big step toward commercialization.
News from Concentrate

Be Sociable, Share!